Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
Kuhle, S
Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. [electronic resource] - Thrombosis and haemostasis Oct 2001 - 1007-11 p. digital
Publication Type: Case Reports; Journal Article; Review
0340-6245
Adolescent
Age of Onset
Amino Acid Substitution
Antithrombin III--chemistry
Antithrombin III Deficiency--epidemiology
Binding Sites
Brain Ischemia--genetics
DNA Mutational Analysis
Female
Genetic Predisposition to Disease
Genotype
Humans
Infant
Infant, Newborn
Infarction, Middle Cerebral Artery--genetics
Male
Mutation, Missense
Point Mutation
Thromboembolism--genetics
Thrombophilia--epidemiology
Venous Thrombosis--genetics
Yugoslavia--epidemiology
Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. [electronic resource] - Thrombosis and haemostasis Oct 2001 - 1007-11 p. digital
Publication Type: Case Reports; Journal Article; Review
0340-6245
Adolescent
Age of Onset
Amino Acid Substitution
Antithrombin III--chemistry
Antithrombin III Deficiency--epidemiology
Binding Sites
Brain Ischemia--genetics
DNA Mutational Analysis
Female
Genetic Predisposition to Disease
Genotype
Humans
Infant
Infant, Newborn
Infarction, Middle Cerebral Artery--genetics
Male
Mutation, Missense
Point Mutation
Thromboembolism--genetics
Thrombophilia--epidemiology
Venous Thrombosis--genetics
Yugoslavia--epidemiology